#eps decline

1 story

#business #earnings #johnson and johnson #medtech #money #q3 2026 #revenue growth #talc litigation

JNJ Q3 Earnings Drop Amid Talc Litigation
Johnson & Johnson's Q3 earnings fell as talc litigation costs and medtech slowdown hit.
Seekingalpha · 1m